Aurobindo Pharma stock growth reflects a strong 16.3% increase in Q1, showcasing the company's market resilience and potential.
Read More
Otic Suspension Approval: Quick and Proven Benefits
Otic Suspension Approval has been granted by USFDA, ensuring safe treatment options for patients.
Read More
Lupin Modafinil approval: Is it the Worst News for Investors?
Lupin Modafinil approval has raised concerns as share prices dip. What does this mean for investors?
Read More